Arianna Draghi

681 total citations
28 papers, 458 citations indexed

About

Arianna Draghi is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Arianna Draghi has authored 28 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 19 papers in Immunology and 3 papers in Genetics. Recurrent topics in Arianna Draghi's work include Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (15 papers) and CAR-T cell therapy research (12 papers). Arianna Draghi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (15 papers) and CAR-T cell therapy research (12 papers). Arianna Draghi collaborates with scholars based in Denmark, Sweden and United Kingdom. Arianna Draghi's co-authors include Marco Donia, Inge Marie Svane, Christopher A. Chamberlain, Troels Holz Borch, Sine Reker Hadrup, Rikke Andersen, Andrew J.S. Furness, Zoltán Szállási, Annie Borch and Özcan Met and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Arianna Draghi

26 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arianna Draghi Denmark	12	316	287	111	58	35	28	458
Lillian Sun United States	7	378 1.2×	298 1.0×	120 1.1×	63 1.1×	29 0.8×	9	508
Kelli A. Connolly United States	6	305 1.0×	312 1.1×	113 1.0×	56 1.0×	25 0.7×	13	479
Elizabeth Gaughan United States	10	261 0.8×	188 0.7×	124 1.1×	79 1.4×	17 0.5×	28	395
David A. Clump United States	11	297 0.9×	171 0.6×	149 1.3×	80 1.4×	76 2.2×	15	453
Jean‐Nicolas Lodewyckx Belgium	4	351 1.1×	277 1.0×	86 0.8×	63 1.1×	18 0.5×	7	455
Brian H. Ladle United States	9	348 1.1×	541 1.9×	234 2.1×	39 0.7×	25 0.7×	25	709
Stephanie Mittman United States	6	356 1.1×	377 1.3×	90 0.8×	49 0.8×	12 0.3×	7	516
Xiangyan Qiu China	3	298 0.9×	345 1.2×	72 0.6×	41 0.7×	21 0.6×	6	453
Gabriel Abril-Rodríguez United States	7	242 0.8×	178 0.6×	130 1.2×	71 1.2×	12 0.3×	9	373
Peggy Richard-Fiardo France	8	193 0.6×	139 0.5×	103 0.9×	38 0.7×	25 0.7×	11	340

Countries citing papers authored by Arianna Draghi

Since Specialization

Citations

This map shows the geographic impact of Arianna Draghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arianna Draghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arianna Draghi more than expected).

Fields of papers citing papers by Arianna Draghi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arianna Draghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arianna Draghi. The network helps show where Arianna Draghi may publish in the future.

Co-authorship network of co-authors of Arianna Draghi

This figure shows the co-authorship network connecting the top 25 collaborators of Arianna Draghi. A scholar is included among the top collaborators of Arianna Draghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arianna Draghi. Arianna Draghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Draghi, Arianna, Annie Borch, Filip Mundt, et al.. (2024). Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways. Cancer Immunology Research. 12(9). 1202–1220. 6 indexed citations

Draghi, Arianna, Christopher A. Chamberlain, Mads Hald Andersen, et al.. (2023). Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma. Clinical Cancer Research. 29(19). 3937–3947. 11 indexed citations

Draghi, Arianna, Joachim Stoltenborg Granhøj, Christina W. Yde, et al.. (2023). Final results: Dose escalation study of a personalized peptide-based neoantigen vaccine in patients with metastatic melanoma.. Journal of Clinical Oncology. 41(16_suppl). 9551–9551. 3 indexed citations

Lee, Moon Hee, Jani Huuhtanen, Petrus Järvinen, et al.. (2023). Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma. Cancer Research Communications. 3(7). 1260–1276. 6 indexed citations

Nielsen, Morten, Zsófia Sztupinszki, Arianna Draghi, et al.. (2022). Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post–PD-1 Immunotherapy. Cancer Immunology Research. 10(10). 1254–1262. 9 indexed citations

Bol, Kalijn F., Arianna Draghi, Nana Haahr Overgaard, et al.. (2022). Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma. Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU). 38 indexed citations

Draghi, Arianna, B Hasselbalch, Christina W. Yde, et al.. (2022). PL02.3.A Survival and T-cell tumor reactivity in patients treated with nivolumab and bevacizumab for recurrent glioblastoma in the clinical trial CA209-9UP. Neuro-Oncology. 24(Supplement_2). ii2–ii3. 2 indexed citations

Chen, Inna M., Marco Donia, Christopher A. Chamberlain, et al.. (2022). Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R). European Journal of Cancer. 180. 125–133. 23 indexed citations

Tvingsholm, Siri, Annie Borch, Arianna Draghi, et al.. (2021). Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive transfer with tumor-infiltrating lymphocytes in melanoma. UCL Discovery (University College London). 77 indexed citations

10.

Draghi, Arianna, Christopher A. Chamberlain, Shawez Khan, et al.. (2021). Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens. Frontiers in Immunology. 12. 705422–705422. 14 indexed citations

11.

Lauss, Martin, Katja Harbst, Christopher A. Chamberlain, et al.. (2021). Transcriptomic signatures of tumors undergoing T cell attack. Cancer Immunology Immunotherapy. 71(3). 553–563. 6 indexed citations

12.

Borch, Annie, Morten Hansen, Arianna Draghi, et al.. (2020). Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome. Cytotherapy. 22(4). 204–213. 12 indexed citations

13.

Westergaard, Marie Christine Wulff, et al.. (2020). The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro. Cancer Immunology Immunotherapy. 70(6). 1771–1776. 11 indexed citations

14.

Ramskov, Sofie, Anne-Mette Bjerregaard, Annie Borch, et al.. (2020). Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations. Frontiers in Immunology. 11. 373–373. 29 indexed citations

15.

Draghi, Arianna, Cathrin Ritter, Tina Seremet, et al.. (2019). MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells. Cancer Immunology Research. 7(9). 1472–1484. 40 indexed citations

16.

Ramskov, Sofie, Theo Sturm, Annie Borch, et al.. (2019). HLA-C restricted neoepitopes contribute significantly to the immune recognition of cancer. Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU). 1 indexed citations

17.

Andersen, Rikke, Troels Holz Borch, Arianna Draghi, et al.. (2018). T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression. Annals of Oncology. 29(7). 1575–1581. 51 indexed citations

18.

Draghi, Arianna, Christopher A. Chamberlain, Andrew J.S. Furness, & Marco Donia. (2018). Acquired resistance to cancer immunotherapy. Seminars in Immunopathology. 41(1). 31–40. 35 indexed citations

19.

Caponnetto, S, Arianna Draghi, Troels Holz Borch, et al.. (2018). Cancer immunotherapy in patients with brain metastases. Cancer Immunology Immunotherapy. 67(5). 703–711. 13 indexed citations

20.

Draghi, Arianna, et al.. (2018). Differential effects of corticosteroids and anti‐TNF on tumor‐specific immune responses: implications for the management of irAEs. International Journal of Cancer. 145(5). 1408–1413. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact